HURA TUHURA BIOSCIENCES INC Product Launches 8-K Filing 2024 - Clinical Trial Results Kintara Therapeutics and TuHURA Biosciences announced positive results from a clinical trial for IFx-2.0 in patients with advanced skin cancers.Get access to all SEC 8-K filings of the TUHURA BIOSCIENCES INC